###begin article-title 0
CBFbeta is a facultative Runx partner in the sea urchin embryo
###end article-title 0
###begin p 1
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
###end p 1
###begin title 2
Background
###end title 2
###begin p 3
###xml 367 395 355 383 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Stronylocentrotus purpuratus</italic>
Runx proteins are developmentally important metazoan transcription factors that form a heterodimeric complex with the non-homologous protein Core Binding Factor beta (CBFbeta). CBFbeta allosterically enhances Runx DNA binding but does not bind DNA itself. We report the initial characterization of SpCBFbeta, the heterodimeric partner of SpRunt-1 from the sea urchin Stronylocentrotus purpuratus.
###end p 3
###begin title 4
Results
###end title 4
###begin p 5
###xml 697 703 688 694 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SpPKC1</italic>
###xml 803 810 791 798 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SpPKC1 </italic>
###xml 1167 1174 1152 1159 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CyIIIa </italic>
###xml 1210 1217 1195 1202 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SpPKC1 </italic>
SpCBFbeta is remarkably similar to its mammalian homologues, and like them it enhances the DNA binding of the Runt domain. SpCBFbeta is entirely of zygotic provenance and its expression is similar that of SpRunt-1, accumulating globally at late blastula stage then later localizing to endoderm and oral ectoderm. Unlike SpRunt-1, however, SpCBFbeta is enriched in the endodermal mid- and hindgut of the pluteus larva, and is not highly expressed in the foregut and ciliated band. We showed previously that morpholino antisense-mediated knockdown of SpRunt-1 leads to differentiation defects, as well as to extensive post-blastula stage apoptosis caused by under-expression of the Runx target gene SpPKC1. In contrast, we show here that knockdown of SpCBFbeta does not negatively impact cell survival or SpPKC1 expression, although it does lead to differentiation defects similar to those associated with SpRunt-1 deficiency. Moreover, SpRunt-1 containing a single amino acid substitution that abolishes its ability to interact with SpCBFbeta retains the ability to rescue cell survival in SpRunt-1 morphant embryos. Chromatin immunoprecipitation shows that while the CyIIIa promoter engages both proteins, the SpPKC1 promoter only engages SpRunt-1.
###end p 5
###begin title 6
Conclusion
###end title 6
###begin p 7
SpCBFbeta is a facultative Runx partner that appears to be required specifically for cell differentiation.
###end p 7
###begin title 8
Background
###end title 8
###begin p 9
###xml 172 173 172 173 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B1">1</xref>
###xml 322 323 322 323 <sup xmlns:xlink="http://www.w3.org/1999/xlink">T</sup>
###xml 324 325 324 325 <sub xmlns:xlink="http://www.w3.org/1999/xlink">C</sub>
###xml 330 331 330 331 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B2">2</xref>
###xml 332 333 332 333 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B3">3</xref>
###xml 460 463 460 463 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 526 532 526 532 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CyIIIa</italic>
###xml 599 606 599 606 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CyIIIa </italic>
###xml 607 608 607 608 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 609 610 609 610 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 613 622 613 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SpRunt-1 </italic>
###xml 818 819 818 819 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
###xml 952 953 952 953 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 969 970 969 970 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 1077 1083 1077 1083 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SpPKC1</italic>
###xml 1132 1133 1132 1133 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
Runx proteins are transcription factors that function critically in gene regulatory networks that control cell proliferation and differentiation during animal development [1]. The Runx family is defined by a highly conserved 128 amino acid sequence known as the Runt domain, which binds specifically to the DNA sequence TGT/CGGT [2,3]. The sea urchin Runx transcription factor SpRunt-1 was discovered biochemically as a protein that binds this sequence in the cis-regulatory domain of the aboral ectoderm differentiation gene CyIIIa, an interaction that contributes to transcriptional activation of CyIIIa [4,5]. SpRunt-1 transcripts are globally expressed in the early embryo, and then become localized predominantly to regions of continued growth and cell proliferation within larval oral ectoderm and endomesoderm [6]. Morpholino antisense-mediated knockdown of SpRunt-1 has shown that it is required throughout the embryo for cell differentiation [7] and survival [8]. The latter function is mediated by a positively-acting interaction between SpRunt-1 and its target gene SpPKC1, which encodes a conventional protein kinase C [8].
###end p 9
###begin p 10
###xml 201 202 198 199 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 315 317 309 311 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B10">10</xref>
###xml 415 417 409 411 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B11">11</xref>
Runx proteins heterodimerize with another protein commonly referred to as core binding factor beta (CBFbeta), a non-DNA binding protein that allosterically enhances the DNA binding of the Runt domain [9]. Mammalian CBFbeta also increases the half-life of Runx1 by protecting it from ubiquitin-mediated proteolysis [10]. Since Runx1 contributes to cell cycle control and its protein levels are cell cycle regulated [11], this suggests that CBFbeta may be a regulatory subunit that modulates Runx activity during the developmental transition from proliferation to terminal differentiation.
###end p 10
###begin p 11
###xml 12 17 12 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CBFb </italic>
###xml 93 95 93 95 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B12">12</xref>
###xml 96 98 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B13">13</xref>
###xml 156 161 156 161 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1</italic>
###xml 171 176 171 176 <italic xmlns:xlink="http://www.w3.org/1999/xlink">RUNX1</italic>
###xml 215 220 215 220 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CBFb </italic>
###xml 265 266 265 266 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 274 279 274 279 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx2</italic>
###xml 281 286 281 286 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CBFb </italic>
###xml 415 421 415 421 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx2 </italic>
###xml 480 482 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B14">14</xref>
###xml 483 485 483 485 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B15">15</xref>
###xml 488 499 488 499 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 522 530 519 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">brother </italic>
###xml 534 545 531 542 <italic xmlns:xlink="http://www.w3.org/1999/xlink">big brother</italic>
###xml 652 653 649 650 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B9">9</xref>
###xml 1062 1064 1053 1055 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B16">16</xref>
###xml 1117 1119 1108 1110 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B17">17</xref>
###xml 1218 1220 1209 1211 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B18">18</xref>
###xml 1395 1397 1383 1385 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B19">19</xref>
###xml 1415 1420 1403 1408 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CBFb </italic>
###xml 1522 1528 1510 1516 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Runx1 </italic>
###xml 1611 1613 1599 1601 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B20">20</xref>
###xml 2035 2038 2020 2023 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 20 25 <span type="species:ncbi:10090">mouse</span>
###xml 249 254 <span type="species:ncbi:9606">human</span>
###xml 488 498 <span type="species:ncbi:7227">Drosophila</span>
###xml 1223 1228 <span type="species:ncbi:10090">Mouse</span>
Knockout of CBFb in mouse leads to embryonic lethality caused by a failure of hematopoiesis [12,13], a phenotype very similar to that caused by knockout of Runx1. As with RUNX1, chromosomal translocations involving CBFb are commonly associated with human leukemia [9]. Like Runx2, CBFb has also been shown to be important for osteogenesis, although its loss-of-function phenotype is not identical to that caused by Runx2 knockout since some osteoblast differentiation does occur [14,15]. Drosophila has two CBFbeta genes, brother and big brother, the products of which contribute redundantly to the functionality of the Runx proteins Runt and Lozenge [9]. These studies all indicate that CBFbeta is important for Runx function; however, to date, no studies have definitively addressed the question of whether the Runx-CBFbeta interaction is constitutive (obligate or context-independent) or facultative (regulatory or context dependent). The latter possibility is suggested by the facts that (a) the interaction is inhibited by sequences within mammalian Runx2 [16] and the C-terminal domains of some Runx1 isoforms [17], and (b) Runx proteins can bind DNA as a monomer, albeit less effectively than as a heterodimer [18]. Mouse CBFbeta, which is ubiquitously expressed, has been shown to interact specifically with another protein termed Crl-1, which is expressed in subsets of neuronal cells [19]. Finally, avian CBFb displays a complex pattern of expression in early development that is not identical to the pattern of Runx1 expression, with some regions of the embryo expressing only one or the other gene [20]. Taken together, these observations invite speculation that Runx proteins might interact with only a subset of target genes (or with some target genes only part of the time) as a heterodimer with CBFbeta, and that the choice between these alternative states may in part be determined by the specific Runx isoform as well as protein-protein interactions specified by the context of each particular tissue, cell type, and cis-regulatory system.
###end p 11
###begin p 12
###xml 123 152 120 149 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Strongylocentrotus purpuratus</italic>
###xml 357 363 348 354 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CyIIIa</italic>
###xml 432 438 423 429 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SpPKC1</italic>
###xml 515 516 506 507 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 123 152 <span type="species:ncbi:7668">Strongylocentrotus purpuratus</span>
Here we describe the cloning and initial characterization of SpCBFbeta, the heterodimeric Runx partner from the sea urchin Strongylocentrotus purpuratus. We show that SpCBFbeta is expressed in a pattern that is similar but not identical to that of SpRunt-1. Moreover, while SpCBFbeta participates in the Runx-dependent activation of several genes including CyIIIa, it is not required for or involved in Runx-dependent activation of SpPKC1, which we showed previously to be critical for cell survival in the embryo [8]. Therefore, heterodimerization of SpRunt-1 with SpCBFbeta occurs facultatively in the sea urchin, and is a context-dependent aspect of Runx-mediated transcriptional control.
###end p 12
###begin title 13
Results and Discussion
###end title 13
###begin title 14
SpCBFbeta expression during embryogenesis
###end title 14
###begin p 15
###xml 75 89 72 86 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. purpuratus </italic>
###xml 462 464 453 455 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 704 714 692 702 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SpCBFbeta </italic>
###xml 749 763 737 751 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. purpuratus </italic>
###xml 780 782 768 770 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B21">21</xref>
###xml 869 879 857 867 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SpCBFbeta </italic>
###xml 919 933 907 921 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. purpuratus </italic>
###xml 1026 1028 1014 1016 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 1048 1059 1036 1047 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila </italic>
###xml 1065 1069 1053 1057 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bro </italic>
###xml 1073 1077 1061 1065 <italic xmlns:xlink="http://www.w3.org/1999/xlink">bgb </italic>
###xml 1104 1115 1092 1103 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. elegans </italic>
###xml 1280 1282 1268 1270 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1A</xref>
###xml 75 88 <span type="species:ncbi:7668">S. purpuratus</span>
###xml 749 762 <span type="species:ncbi:7668">S. purpuratus</span>
###xml 919 932 <span type="species:ncbi:7668">S. purpuratus</span>
###xml 1048 1058 <span type="species:ncbi:7227">Drosophila</span>
###xml 1104 1114 <span type="species:ncbi:238774|species:ncbi:386067|species:ncbi:147878|species:ncbi:193182|species:ncbi:313250|species:ncbi:323266|species:ncbi:315362|species:ncbi:148887|species:ncbi:124036|species:ncbi:48798|species:ncbi:529401|species:ncbi:314391|species:ncbi:646318|species:ncbi:254962|species:ncbi:323047|species:ncbi:287681|species:ncbi:269614|species:ncbi:103475|species:ncbi:114942|species:ncbi:212608|species:ncbi:457136|species:ncbi:227469|species:ncbi:449387|species:ncbi:551876|species:ncbi:248142|species:ncbi:252961|species:ncbi:466267|species:ncbi:119832|species:ncbi:228196|species:ncbi:316080|species:ncbi:217897|species:ncbi:109099|species:ncbi:328850|species:ncbi:266263|species:ncbi:348465|species:ncbi:181251|species:ncbi:6239|species:ncbi:320029|species:ncbi:293163|species:ncbi:4853|species:ncbi:160529|species:ncbi:292745|species:ncbi:368875|species:ncbi:323318|species:ncbi:209968|species:ncbi:405608|species:ncbi:480533">C. elegans</span>
Sequences encoding the sea urchin homologue of CBFbeta were amplified from S. purpuratus blastula stage cDNA by polymerase chain reaction (PCR) using degenerate primers corresponding to highly conserved regions of the protein. The resulting amplicon was cloned and sequenced, and the sequence was used to obtain the full-length SpCBFbeta mRNA by 5' and 3' RACE. The SpCBFbeta mRNA encodes a protein with a predicted molecular weight of ~21 kDa. As shown in Fig. 1A, the deduced amino acid sequence of SpCBFbeta is highly similar to that of its homologues from other phyla, and as would be expected, is more similar to the vertebrate representatives than to those from the non-deuterostome invertebrates. SpCBFbeta gene sequences were located in the S. purpuratus genome database [21], and the exon-intron structure of the gene was deduced from alignment with the cDNA. SpCBFbeta appears to be the only homologue in the S. purpuratus genome, and contains four introns, the positions of which are conserved in vertebrates (Fig. 1A). In contrast, the Drosophila genes bro and bgb have no introns, while the C. elegans homologue is missing introns 1 and 4 (with its second intron displaced upstream in the coding sequence with respect to intron 3 of the deuterostome homologues; Fig. 1A).
###end p 15
###begin p 16
###xml 263 270 260 267 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CyIIIa </italic>
###xml 271 272 268 269 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 575 577 566 568 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 643 645 631 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1B</xref>
###xml 919 920 904 905 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B4">4</xref>
###xml 1237 1239 1216 1218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 1328 1330 1307 1309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 1396 1398 1375 1377 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 1482 1484 1461 1463 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F1">1C</xref>
###xml 1570 1577 1546 1553 <italic xmlns:xlink="http://www.w3.org/1999/xlink">in vivo</italic>
Electrophoretic mobility shift analysis (EMSA) was used to test whether SpCBFbeta enhances the DNA binding activity of SpRunt-1. Recombinant SpRunt-1 protein was reacted with a fluorescently labeled oligonucleotide probe containing the SpRunt-1 binding site from CyIIIa [5], either with or without pre-incubation with recombinant SpCBFbeta. DNA binding of full-length SpRunt-1, or a fragment containing only the Runt domain thereof, is substantially enhanced in the presence of SpCBFbeta, which forms a complex with the SpRunt-1 protein (as indicated by a "supershift"; Fig. 1B, lanes 2 and 4), whereas SpCBFbeta alone does not bind DNA (Fig. 1B, lane 5). It is likely that native SpRunt-1 forms a heterodimeric complex with SpCBFbeta in the embryo, and consistent with this, affinity purified SpRunt-1 protein from blastula stage nuclear extracts was initially identified as a heterodimer containing a 21 kDa subunit [4]. To confirm this, an antibody generated against recombinant SpCBFbeta was used to probe an immunoblot of whole nuclear extract, nuclear extract immunodepleted with an anti-SpRunt-1 antibody, and the resulting immunoprecipitate. A 21 kDa SpCBFbeta-immunoreactive band present in blastula stage nuclear extract (Fig. 1C, lane 1) is specifically immunodepleted from the extract by the SpRunt-1 antibody (Fig. 1C, lane 2), and pulled down in the SpRunt-1 immuoprecipitate (Fig. 1C, lane 3), whereas the band is not similarly precipitated by non-specific IgG (Fig. 1C, lanes 4 and 5). These data suggest that SpCBFbeta exists in a complex with SpRunt-1 in vivo.
###end p 16
###begin p 17
###xml 219 221 216 218 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2A</xref>
###xml 532 534 523 525 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2B</xref>
###xml 578 579 569 570 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 654 656 645 647 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F2">2C</xref>
RNA blot analysis shows that SpCBFbeta is represented by a single species of transcript that is virtually absent in the egg and early embryo, and which accumulates dramatically during blastula and gastrula stages (Fig. 2A). The temporal expression of SpCBFbeta was further examined by quantitative reverse transcription-coupled PCR (qRT-PCR). SpCBFbeta transcripts are present at low levels during cleavage, accumulate approximately 25-fold between 9 and 40 hours post-fertilization (hpf), and thereafter decline in abundance (Fig. 2B). This pattern parallels that of SpRunt-1 [5], although possibly with a slight temporal lag. Immunoblot analysis (Fig. 2C) reveals that there is no maternal SpCBFbeta protein, and that zygotic accumulation of SpCBFbeta protein is similar to that of its mRNA, although unlike the mRNA the protein levels do not increase significantly between 24 and 40 h, suggesting that there may be translational or post-translational regulation during this interval.
###end p 17
###begin p 18
###xml 327 328 321 322 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
Quantitative RT-PCR was also used to measure the abundance of SpCBFbeta transcripts. Toward this end a standard curve was constructed from in vitro synthesized SpCBFbeta mRNA (see Methods). We used the same method to measure the abundance of SpRunt-1 transcripts, which were previously measured by an RNAase protection method [5]. The measurements of SpRunt-1 were in agreement with our previous measurements, indicating 7,000-8,000 transcripts per blastula or gastrula stage embryo. In the mid-gastrula stage embryo, when SpCBFbeta is maximally expressed, it is present at slightly higher levels than is SpRunt-1, determined by qRT-PCR to be 12,000 transcripts per embryo. Thereafter, SpCBFbeta transcripts decline in abundance to levels approximating those of SpRunt-1.
###end p 18
###begin p 19
###xml 108 109 105 106 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3</xref>
###xml 417 421 411 415 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A&#8211;G</xref>
###xml 550 554 544 548 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3A&#8211;C</xref>
###xml 626 630 620 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3D&#8211;F</xref>
###xml 681 683 675 677 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3G</xref>
###xml 841 845 832 836 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3H&#8211;J</xref>
###xml 954 956 945 947 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F3">3K</xref>
###xml 1174 1175 1165 1166 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
The spatial pattern of SpCBFbeta expression was examined by whole mount in situ hybridization (WMISH) (Fig. 3). As with its temporal expression, SpCBFbeta is expressed initially in a spatial pattern that is similar to that of SpRunt-1: at mesenchyme blastula stage, transcripts are globally distributed (not shown), and by late gastrula stage, they start to become enriched in the oral ectoderm and endomesderm (Fig. 3A-G; arrows in 3E, F). In the 2-day old gastrula endoderm expression is highest in a ring of cells just inside the blastopore (Fig. 3A-C; arrows in 3A). Expression is also enhanced in the oral ectoderm (Fig. 3D-F) and on the oral side of the hindgut region (Fig. 3G, arrow). In the mature (4-day) pluteus, SpCBFbeta transcripts are expressed most prominently in the differentiating midgut and hindgut of the endoderm (Fig. 3H-J; arrows in 3J), whereas in the ciliated band, expression is confined to the tips of the anal arm buds (Fig. 3K, arrows). This is somewhat different from the larval expression pattern of SpRunt-1, which is also expressed in the endoderm but most prominently in the larval foregut region, as well as throughout the ciliated band [6].
###end p 19
###begin title 20
SpCBFbeta is dispensable for the pro-survival function of SpRunt-1
###end title 20
###begin p 21
###xml 253 254 250 251 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4</xref>
###xml 398 400 392 394 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4F</xref>
###xml 491 493 485 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4F</xref>
###xml 631 633 622 624 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4F</xref>
###xml 716 718 707 709 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B22">22</xref>
###xml 1021 1023 1006 1008 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F4">4G</xref>
A morpholino antisense oligonucleotide (MASO) was designed to target the translational start site in the SpCBFbeta mRNA. Introduction of this MASO into embryos produces a distinctive phenotype that is milder than that obtained with SpRunt-1 MASOs (Fig. 4). While SpCBFbeta morphants display morphological defects, most notably a failure of skeletogenesis and a poorly differentiated ectoderm (Fig. 4F and see gene expression analysis below), unlike SpRunt-1 morphants, they gastrulate (Fig. 4F, arrow). The SpCBFbeta morphants also have a secondary axis and appear to form bilateral clusters of skeletogenic mesenchyme cells (Fig. 4F, arrowhead), which normally occurs in response to signals from the oral ectoderm [22], suggesting that the ectodermal and skeletogenic differentiation defects are not caused by a failure of regional specification, but rather of subsequent cell differentiation. That the SpCBFbeta MASO effectively depletes embryos of SpCBFbeta is shown by immunoblot analysis of endogenous protein (Fig. 4G).
###end p 21
###begin p 22
###xml 181 182 181 182 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 404 406 401 403 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5A</xref>
###xml 486 488 480 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5B</xref>
The gastrulation defective phenotype associated with SpRunt-1 deficiency is largely a secondary effect of extensive apoptosis that occurs throughout the post-blastula stage embryo [8]. Since SpCBFbeta morphants gastrulate, we hypothesized that they do not undergo the extensive apoptosis characteristic of SpRunt-1 morphants. This is indeed the case: unlike embryos injected with the SpRunt-1 MASO (Fig. 5A), those injected with the SpCBFbeta MASO display negligible TUNEL signal (Fig. 5B). This suggests that SpCBFbeta is dispensable for SpRunt-1 function in promoting cell survival.
###end p 22
###begin p 23
###xml 82 83 82 83 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 703 705 691 693 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5C</xref>
###xml 786 788 774 776 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F5">5D</xref>
SpRunt-1 derived from exogenous mRNA rescues cell survival in SpRunt-1 morphants [8]. If SpCBFbeta is dispensable for the survival function of SpRunt-1, then a SpRunt-1 protein that has been mutated so that it cannot interact with SpCBFbeta should retain the ability to rescue cell survival in SpRunt-1 morphants. To test this, we constructed a SpRunt-1 mutant protein wherein an arginine is substituted for a glycine residue that is essential for the interaction between the Runt domain and CBFbeta (SpRunt-1-G115R). Electrophoretic mobility shift analysis verifies that the Runt domain from SpRunt-1-G115R retains the ability to bind DNA as a monomer, but does not heterodimerize with SpCBFbeta (Fig. 5C). Importantly, SpRunt-1-G115R rescues cell survival in SpRunt-1 morphants (Fig. 5D), indicating that heterodimerization with SpCBFbeta is not required for the anti-apoptotic function of SpRunt-1.
###end p 23
###begin title 24
###xml 0 7 0 7 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SpPKC1 </italic>
SpPKC1 is a SpCBFbeta-independent Runx target
###end title 24
###begin p 25
###xml 111 117 111 117 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SpPKC1</italic>
###xml 204 205 204 205 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 373 379 367 373 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SpPKC1</italic>
###xml 470 477 464 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SpPKC1 </italic>
###xml 575 582 566 573 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SpPKC1 </italic>
###xml 746 748 734 736 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 821 828 809 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CyIIIa </italic>
###xml 970 971 955 956 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 974 984 959 969 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SpCyclinD </italic>
###xml 988 994 973 979 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SpDri </italic>
###xml 1105 1107 1090 1092 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B23">23</xref>
###xml 1116 1118 1101 1103 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6A</xref>
###xml 1200 1206 1185 1191 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CyIIIa</italic>
###xml 1208 1218 1193 1203 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SpCyclinD </italic>
###xml 1222 1228 1207 1213 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SpDri </italic>
###xml 1312 1319 1294 1301 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SpPKC1 </italic>
###xml 1344 1351 1326 1333 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CyIIIa </italic>
###xml 1418 1425 1400 1407 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SpPKC1 </italic>
###xml 1543 1544 1525 1526 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 1585 1587 1567 1569 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B24">24</xref>
###xml 1614 1621 1596 1603 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SpPKC1 </italic>
###xml 1738 1748 1720 1730 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SpPKC1 cis</italic>
The apoptotic phenotype in SpRunt-1 deficient embryos is specifically caused by a deficit in the expression of SpPKC1, a direct regulatory target of SpRunt-1 that encodes a conventional protein kinase C [8]. The fact that SpCBFbeta-deficient embryos do not display an apoptotic phenotype suggests that loss of SpCBFbeta function does not adversely affect the expression of SpPKC1. To test this we used reverse transcription-coupled PCR to measure the relative levels of SpPKC1 transcripts in either SpRunt-1 morphants or SpCBFbeta morphants with respect to controls. Whereas SpPKC1 is ~7-fold under-expressed in SpRunt-1-deficient gastrula stage embryos, its expression at that stage is not significantly affected by knockdown of SpCBFbeta (Fig. 6A). In contrast, expression of the aboral ectoderm differentiation marker CyIIIa is diminished to an equivalent extent by knockdown of either SpRunt-1 or SpCBFbeta, as are expression of two other putative SpRunt-1 targets [7], SpCyclinD and SpDri (the latter encodes a transcription factor required both for oral ectoderm differentiation and skeletogenesis [23]) (Fig. 6A). These results indicate that at gastrula stage, SpRunt-1-mediated activation of CyIIIa, SpCyclinD and SpDri requires heterodimerization with SpCBFbeta, whereas SpRunt-1-mediated activation of SpPKC1 does not. Interestingly, CyIIIa expression is not as strongly affected by SpRunt-1 depletion as is SpPKC1 expression; this could relate to the fact that the splice-blocking MASO does not completely deplete SpRunt-1 protein [7], some of which is provided maternally [24]. These data suggest that SpPKC1 activity is particularly sensitive to SpRunt-1 protein levels, which might occur if the architectural context of the SpPKC1 cis-regulatory system confers selectivity for zygotically-expressed SpRunt-1 and/or SpRunt-1 isoforms that cannot heterodimerize with SpCBFbeta.
###end p 25
###begin p 26
###xml 98 104 95 101 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SpPKC1</italic>
###xml 231 238 225 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SpPKC1 </italic>
###xml 478 485 469 476 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CyIIIa </italic>
###xml 541 548 532 539 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CyIIIa </italic>
###xml 624 634 615 625 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SpCyclinD </italic>
###xml 640 642 631 633 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 685 692 676 683 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SpPKC1 </italic>
###xml 807 809 795 797 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="fig" rid="F6">6B</xref>
###xml 951 958 936 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SpPKC1 </italic>
While these results indicate that SpCBFbeta is not required for the transcriptional activation of SpPKC1, they do not rule out the possibility that SpCBFbeta nonetheless heterodimerizes with SpRunt-1 on its target sequences in the SpPKC1 promoter. To address this issue, we performed chromatin immunoprecipitation (ChIP) of chromatin prepared from late gastrula stage embryos using antibodies to either SpRunt-1 or SpCBFbeta. Consistent with the expression data indicating that CyIIIa activation requires the heterodimer, sequences from the CyIIIa promoter are recovered by ChIP using both antibodies, as are sequences from SpCyclinD (Fig. 6B). In contrast, whereas sequences from the SpPKC1 promoter are recovered by ChIP using the SpRunt-1 antibody, they are not recovered by the SpCBFbeta antibody (Fig. 6B). We conclude that in the gastrula stage embryo, SpCBFbeta does not exist in a heterodimeric complex with SpRunt-1 within the context of the SpPKC1 promoter.
###end p 26
###begin title 27
Conclusion
###end title 27
###begin p 28
###xml 194 201 191 198 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SpPKC1 </italic>
###xml 201 204 198 201 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
###xml 683 686 674 677 <italic xmlns:xlink="http://www.w3.org/1999/xlink">cis</italic>
Our data are consistent with the proposition that CBFbeta is a facultative Runx partner that participates in the regulation of a subset of Runx target genes. It will be important to analyze the SpPKC1 cis-regulatory system to learn the contextual rules that facilitate CBFbeta-independent Runx function, and to determine the biological rationale for Runx-mediated transcriptional regulation that does not involve CBFbeta. One intriguing possibility is that genes that need to be rapidly responsive to physiological signals require Runx-DNA binding complexes that are less stable and/or have shorter half lives. Addressing this issue will require identification and comparison of the cis-regulatory systems from additional CFBbeta-dependent and -independent Runx target genes.
###end p 28
###begin title 29
Methods
###end title 29
###begin title 30
Animals
###end title 30
###begin p 31
###xml 6 36 6 36 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Strongylocentrotus purpuratus </italic>
###xml 240 241 240 241 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 6 35 <span type="species:ncbi:7668">Strongylocentrotus purpuratus</span>
Adult Strongylocentrotus purpuratus were obtained from Charles Hollahan (Santa Barbara Marine Biologicals, Santa Barbara, CA) or Pat Leahy (Corona del Mar, CA). Gamete collection and embryo culture were carried out as described previously [8].
###end p 31
###begin title 32
Microinjection and imaging of embryos
###end title 32
###begin p 33
###xml 77 78 77 78 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
Embryo microinjections and imaging were carried out as previously described [8].
###end p 33
###begin title 34
Cloning of SpCBFbeta
###end title 34
###begin p 35
###xml 560 574 554 568 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. purpuratus </italic>
###xml 939 943 930 932 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
###xml 1307 1321 1290 1304 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. purpuratus </italic>
###xml 560 573 <span type="species:ncbi:7668">S. purpuratus</span>
###xml 1307 1320 <span type="species:ncbi:7668">S. purpuratus</span>
An alignment of all the known CBFbeta protein sequences was used to design a degenerate PCR primer set. The following oligonucleotide primers were chosen to target conserved regions of the sequence alignment having amino acids with low codon degeneracy: N-terminal region MPRVVPDQ giving forward primer ATG CCI MGI GTI GTI CCI GAY CA, and central region NGVCV(LIR)W(RK)GW giving reverse primer CCA GGI ICK CCA IMD IAC RCA IAC ICC RTT (where M = A+C/Y = C+T/K = T+G/D = A+T+G/R = A+G). The SpCBFbeta message was amplified from total RNA isolated from a 12 hour S. purpuratus embryo culture using 2-step PCR. Random primer was used in the cDNA synthesis step followed by the use of degenerate primers to direct PCR amplification of SpCBFbeta from the random primed template. The single 350 bp PCR product, which was the size expected for a conserved sequence relative to the consensus, was desalted and cloned into plasmid vector pGEM T easy(R) (Promega) by TA cloning. A set of 6 separate clones were fully sequenced and theoretical translation showed clear homology to consensus CBFbeta. The nucleotide sequence of the partial SpCBFbeta clone obtained by PCR with degenerate primers was in turn used to design specific primers for RACE. 5' RACE was performed starting with total RNA isolated from a 24 hour S. purpuratus embryo culture. Using GeneRacertrade mark (Invitrogen) following the manufacturer's protocol with the random primer option, 5' RACE cDNA was synthesized and used as a template for PCR with the included 5' RACE primer as a forward primer and a SpCBFbeta-specific reverse primer. For 3' RACE, the phosphatase and ligation steps described in the GeneRacertrade mark protocol, designed to enrich for the 5' end, were eliminated. 3' RACE cDNA was synthesized with the oligo dT primer option and used as a template for PCR with an SpCBFbeta specific forward primer, the included 3' RACE primer serving as the reverse primer. The final SpCBFbeta sequence (Genbank accession number ) could not be extended further by RACE or database searches and is considered to be full-length.
###end p 35
###begin title 36
Recombinant protein production and electrophoretic mobility shift analysis (EMSA)
###end title 36
###begin p 37
###xml 533 537 530 532 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
Full length SpRunt-1 and the Runt domain thereof were each subcloned from the original pSPORT1 plasmid into the bacterial expression vector pRSET A (Invitrogen). For subcloning, PCR primers were designed to insert the full length or partial coding sequence in frame relative to the his-tag encoded in the vector sequence. Likewise, the full coding region of SpCBFbeta was subcloned into pRSET A downstream of the his-tag. For the SpRunt-1-G115R, base substitutions were made in the SpRunt-1 Runt domain/pRSET clone by the QuickChange(R) II Site-Directed Mutagenesis method (Stratagene), using the following primers: Forward T ACG ATG GTG ACG ATC GCA GCA GGG AAC GAT GAA AAC T and Reverse T ACG ATG GTG ACG ATC GCA GCG CGC AAC GAT GAA AAC T. The based substitutions introduced a unique BssHll site for diagnostic purposes.
###end p 37
###begin p 38
###xml 248 249 248 249 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 269 276 269 276 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CyIIIa </italic>
###xml 308 309 308 309 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 374 384 374 384 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SpCyclinD </italic>
Each of the expression constructs was induced in a BL21-pLysS culture, and protein was isolated from the IPTG-induced culture using a Ni-NTA Spin Kit (Qiagen). EMSA was performed with fluorescently labeled oligonucleotides as previously described [8], using either the CyIIIa Runx site described previously [5] or the following Runx-site oligonucleotides as probe (from the SpCyclinD promoter region): 5'-/5Cy5/ATT ATT CTC TGA CCA CAA TTT TTG TTA GA-3' and 5'-TCT AAC AAA AAT TGT GGT CAG AGA ATA AT-3'.
###end p 38
###begin title 39
RNA blot analysis
###end title 39
###begin p 40
###xml 92 93 92 93 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B6">6</xref>
RNA blot analysis was carried out on total RNA from staged embryos as described previously [6].
###end p 40
###begin title 41
Quantitative reverse transcription-coupled PCR (qRT-PCR)
###end title 41
###begin p 42
###xml 130 131 130 131 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 519 521 513 515 <sup xmlns:xlink="http://www.w3.org/1999/xlink">3 </sup>
###xml 532 534 526 528 <sup xmlns:xlink="http://www.w3.org/1999/xlink">8 </sup>
For quantitation of relative transcript levels in control versus knockdown embryos, RT-PCR was performed as described previously [7], using RNA prepared from either 48 h (for SpPKC1, CyIIIa, and SpDri) or 36 h (for SpCyclinD) embryos. For quantitation of absolute transcript numbers, a SpCBFbeta standard was prepared using the T7 mMessage Machine (Ambion) with the linearized clone as an in-vitro transcription template. After quantitation the SpCBFbeta transcript was diluted in a 10 fold series ranging from 2.5 x 103 to 2.5 x 108 transcript copies and each dilution was adjusted to a final 5 mug amount by the addition of total RNA extracted from eggs (there is no endogenous SpCBFbeta transcript detectable in eggs). Each of the diluted standards as well as 5 mug 24 and 40 hour total RNA samples were amplified by PCR using a 2-step procedure. First strand synthesis was performed using Superscripttrade mark lll (Invitrogen) with the random primer option. PCR was then performed in a SmartCycler II (Cepheid) with SpCBFbeta-specific primers and SYBR green detection. The final standard curve was used along with known values for total RNA yield per embryo and known number of embryos used for the sample RNA extraction to determine the transcript copy number per embryo.
###end p 42
###begin title 43
Antibody production and immunoblot analysis
###end title 43
###begin p 44
###xml 59 60 59 60 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B5">5</xref>
###xml 358 359 352 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 123 130 <span type="species:ncbi:9986">rabbits</span>
The SpRunt-1 polyclonal antibody was described previously [5]. The SpCBFbeta polyclonal antibody was similarly produced in rabbits by Cocalico Biologicals (Reamstown, PA), using purified recombinant SpCBFbeta as antigen. The SLBP antibody was a gift of Dr. William Marzluff (University of North Carolina). Immunoblots were performed as described previously [7].
###end p 44
###begin title 45
Whole mount in situ hybridization (WMISH)
###end title 45
###begin p 46
###xml 64 66 64 66 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B25">25</xref>
###xml 96 98 96 98 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B26">26</xref>
WMISH was performed by the methodology of Ransick and Davidson [25], as described in detail in [26].
###end p 46
###begin title 47
Morpholino antisense oligonucleotides
###end title 47
###begin p 48
###xml 227 228 224 225 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
Morpholino antisense oligonucleotides (MASOs) were designed by and purchased from GeneTools, LLC (Corvallis, OR). The sequence of the SpCBFbeta MASO is: CTACTCTGGGCATAGTTGACATCGG. The SpRunt-1 MASO m5 was described previously [7]. The standard non-specific control MASO from GeneTools was used as a negative control.
###end p 48
###begin title 49
Terminal transferase-mediated dUTP nick end labeling (TUNEL) assay
###end title 49
###begin p 50
###xml 89 90 89 90 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
TUNEL assays on fixed embryos to image apoptosis were performed as previously described [8].
###end p 50
###begin title 51
mRNA synthesis
###end title 51
###begin p 52
###xml 114 115 114 115 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B7">7</xref>
###xml 135 139 135 137 <sup xmlns:xlink="http://www.w3.org/1999/xlink">&#174; </sup>
For rescue experiments, a mutation that changed Gly 115 to Arg was made in the SpRunt-1 full length rescue clone [7] by the QuickChange(R) II Site-Directed Mutagenesis method (Stratagene), using the primers described above for the SpRunt-1 expression plasmid. The T7 mMessage Machine (Ambion) was used to synthesize full-length capped mRNA for microinjection.
###end p 52
###begin title 53
Chromatin immunoprecipitation (ChIP)
###end title 53
###begin p 54
###xml 46 47 46 47 <xref xmlns:xlink="http://www.w3.org/1999/xlink" ref-type="bibr" rid="B8">8</xref>
###xml 343 349 337 343 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SpPKC1</italic>
###xml 434 440 428 434 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CyIIIa</italic>
###xml 524 533 518 527 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SpCyclinD</italic>
###xml 622 628 616 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SpCdk4</italic>
ChIP was carried out as previously described [8], using chromatin prepared from 48 h embryos and polyclonal IgG specific for SpRunt-1 and SpCBFbeta. Non-immune or pre-immune IgG was used as a specificity control for anti-SpRunt-1 and anti-SpCBFbeta antibodies, respectively. The following primers were used for PCR amplification ChIP samples: SpPKC1: GACCCCTGGCTTAATATGTTGATGTGTT (forward) and CCTTCATCTCAAACGAAGAATCCGACAT (reverse); CyIIIa: GTAGCACACGGAGAGATTGTGGGACAT (forward) and GGATCGGGGTTAGAGTTACATTTGGCTT (reverse); SpCyclinD: AGAAACGAATGTATCCGTGTGTTGTGAA (forward) and GCGAGACATAACTTCCTTGATCGTGCTA (reverse); and SpCdk4: CAGGAGCGTAGTCAATCCGCATCAA (forward) and CAGCCTGCAACTTCTGAGATGCTTTGT (reverse).
###end p 54
###begin title 55
Authors' contributions
###end title 55
###begin p 56
AJR cloned the cDNA encoding SpCBFbeta, made all the plasmid constructs, performed the RNA blot analysis, measured SpCBFbeta transcript abundance using qRT-PCR, and assisted with ChIP. CD-S performed most of the microinjections, embryo labeling, confocal imaging and measurements of gene expression. AR performed the whole mount in situ hybridization. DER performed ChIP and EMSA experiments. JJM performed EMSA experiments and expressed the recombinant SpRunt-1 and SpCBFbeta proteins. JAC directed the research, did some of the microinjections, acquired the DIC images, assisted with data analysis and drafted the manuscript and figures.
###end p 56
###begin title 57
Acknowledgements
###end title 57
###begin p 58
We thank Dr. Eric Davidson for reviewing this manuscript prior to submission, the four anonymous reviewers for helpful comments that further improved the manuscript, and the Molecular Biology Core of the Stowers Institute for DNA sequencing. This work was funded by the Stowers Institute for Medical Research and by a grant from the NIH (GM070840).
###end p 58
###begin article-title 59
Runx transcription factors and the developmental balance between cell proliferation and differentiation
###end article-title 59
###begin article-title 60
The Runt domain identifies a new family of heteromeric transcriptional regulators
###end article-title 60
###begin article-title 61
The evolution of Runx genes I. A comparative study of sequences from phylogenetically diverse model organisms
###end article-title 61
###begin article-title 62
Automated sequential affinity chromatography of sea urchin embryo DNA binding proteins
###end article-title 62
###begin article-title 63
SpRunt-1, a new member of the runt domain family of transcription factors, is a positive regulator of the aboral ectoderm-specific CyIIIA gene in sea urchin embryos
###end article-title 63
###begin article-title 64
The expression of SpRunt during sea urchin embryogenesis
###end article-title 64
###begin article-title 65
Evaluation of developmental phenotypes produced by morpholino antisense targeting of a sea urchin Runx gene
###end article-title 65
###begin article-title 66
Runx-dependent expression of PKC is critical for cell survival in the sea urchin embryo
###end article-title 66
###begin article-title 67
Function of CBFbeta/Bro proteins
###end article-title 67
###begin article-title 68
Dimerization with PEBP2beta protects RUNX1/AML1 from ubiquitin- proteasome-mediated degradation
###end article-title 68
###begin article-title 69
AML1/RUNX1 increases during G1 to S cell cycle progression independent of cytokine-dependent phosphorylation and induces cyclin D3 gene expression
###end article-title 69
###begin article-title 70
###xml 40 44 <span type="species:ncbi:10090">mice</span>
Absence of fetal liver hematopoiesis in mice deficient in transcriptional coactivator core binding factor beta
###end article-title 70
###begin article-title 71
The CBFbeta subunit is essential for CBFalpha2 (AML1) function in vivo
###end article-title 71
###begin article-title 72
Core-binding factor beta interacts with Runx2 and is required for skeletal development
###end article-title 72
###begin article-title 73
The core-binding factor beta subunit is required for bone formation and hematopoietic maturation
###end article-title 73
###begin article-title 74
Two domains unique to osteoblast-specific transcription factor Osf2/Cbfa1 contribute to its transactivation function and its inability to heterodimerize with Cbfbeta
###end article-title 74
###begin article-title 75
Auto-inhibition and partner proteins, core-binding factor beta (CBFbeta) and Ets-1, modulate DNA binding by CBFalpha2 (AML1)
###end article-title 75
###begin article-title 76
Structural analyses of DNA recognition by the AML1/Runx-1 Runt domain and its allosteric control by CBFbeta
###end article-title 76
###begin article-title 77
###xml 126 131 <span type="species:ncbi:10090">mouse</span>
Cloning and expression pattern of a novel PEBP2 beta-binding protein (charged amino acid rich leucine zipper-1[Crl-1]) in the mouse
###end article-title 77
###begin article-title 78
Core binding factor in the early avian embryo: cloning of Cbfbeta and combinatorial expression patterns with Runx1
###end article-title 78
###begin article-title 79
Sea Urchin Genome Project
###end article-title 79
###begin article-title 80
###xml 44 65 <span type="species:ncbi:7656">Paracentrotus lividus</span>
Spatially restricted expression of PlOtp, a Paracentrotus lividus orthopedia-related homeobox gene, is correlated with oral ectodermal patterning and skeletal morphogenesis in late-cleavage sea urchin embryos
###end article-title 80
###begin article-title 81
Spdeadringer, a sea urchin embryo gene required separately in skeletogenic and oral ectoderm gene regulatory networks
###end article-title 81
###begin article-title 82
###xml 108 137 <span type="species:ncbi:7668">Strongylocentrotus purpuratus</span>
Extensive maternal representation of DNA-binding proteins that interact with regulatory target sites of the Strongylocentrotus purpuratus CyIIIa gene
###end article-title 82
###begin article-title 83
Micromeres are required for normal vegetal plate specification in sea urchin embryos
###end article-title 83
###begin article-title 84
Detection of mRNA by in situ hybridization and RT-PCR
###end article-title 84
###begin title 85
Figures and Tables
###end title 85
###begin p 86
###xml 0 56 0 53 <bold xmlns:xlink="http://www.w3.org/1999/xlink">SpCBF&#946; structure and heterodimerization with SpRunt-1</bold>
###xml 98 111 92 105 <italic xmlns:xlink="http://www.w3.org/1999/xlink">S. purpuratus</italic>
###xml 133 145 127 139 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Homo sapiens</italic>
###xml 260 270 254 264 <italic xmlns:xlink="http://www.w3.org/1999/xlink">Drosophila</italic>
###xml 305 315 299 309 <italic xmlns:xlink="http://www.w3.org/1999/xlink">C. elegans</italic>
###xml 98 111 <span type="species:ncbi:7668">S. purpuratus</span>
###xml 117 126 <span type="species:ncbi:7955">zebrafish</span>
###xml 133 145 <span type="species:ncbi:9606">Homo sapiens</span>
###xml 200 205 <span type="species:ncbi:10090">mouse</span>
###xml 260 270 <span type="species:ncbi:7227">Drosophila</span>
###xml 305 315 <span type="species:ncbi:238774|species:ncbi:386067|species:ncbi:147878|species:ncbi:193182|species:ncbi:313250|species:ncbi:323266|species:ncbi:315362|species:ncbi:148887|species:ncbi:124036|species:ncbi:48798|species:ncbi:529401|species:ncbi:314391|species:ncbi:646318|species:ncbi:254962|species:ncbi:323047|species:ncbi:287681|species:ncbi:269614|species:ncbi:103475|species:ncbi:114942|species:ncbi:212608|species:ncbi:457136|species:ncbi:227469|species:ncbi:449387|species:ncbi:551876|species:ncbi:248142|species:ncbi:252961|species:ncbi:466267|species:ncbi:119832|species:ncbi:228196|species:ncbi:316080|species:ncbi:217897|species:ncbi:109099|species:ncbi:328850|species:ncbi:266263|species:ncbi:348465|species:ncbi:181251|species:ncbi:6239|species:ncbi:320029|species:ncbi:293163|species:ncbi:4853|species:ncbi:160529|species:ncbi:292745|species:ncbi:368875|species:ncbi:323318|species:ncbi:209968|species:ncbi:405608|species:ncbi:480533">C. elegans</span>
SpCBFbeta structure and heterodimerization with SpRunt-1. (A) Alignment of CBFbeta sequences from S. purpuratus (Sp) zebrafish (Dr), Homo sapiens (Hs, variant 2 of the two mammalian splice variants), mouse (Mm, variant 1 of the two mammalian splice variants), Drosophila (two genes, DmBro and DmBgb), and C. elegans. Amino acid residues that are identical between SpCBFbeta and at least one other homologue are highlighted in black, and conserved substitutions are highlighted in grey. Amino acid pairs of which the respective codons are separated by introns in each gene are underlined; the four introns conserved between urchin and vertebrates are indicated by arrowheads. (B) EMSA analysis using recombinant Runt domain (RD) or full-length SpRunt-1 (FL) either alone or in the presence of recombinant SpCBFbeta. Note that the full-length SpRunt-1 does not bind DNA very effectively by itself, suggesting the presence of domains that inhibit DNA binding within the full length protein. SpCBFbeta complexes with both the Runt domain and full-length SpRunt-1, as indicated by a "supershift", but does not bind DNA by itself. (C) Immunoblot of SpCBFbeta from nuclear extract (NE), and nuclear extract immundepleted (ID) and immunoprecipitated (IP) with anti-SpRunt-1 or nonspecific IgG. Molecular weight markers (in kilodaltons) are shown on the right.
###end p 86
###begin p 87
###xml 0 32 0 29 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Temporal expression of SpCBF&#946;</bold>
Temporal expression of SpCBFbeta. (A) Northern blot of total RNA from egg, morula, blastula, and gastrula stage embryos probed with SpCBFbeta. The ethidium bromide stained rRNA bands from the same gel are shown as a loading control. (B) Temporal expression of SpCBFbeta as measured by RT-PCR. (C) Immunoblot of equivalent amounts of total protein from egg (E), morula (M), early blastula (EB), mesenchyme blastula (MB), early gastrula (EG), late gastrula (LG) and pluteus stage (P), probed with antibodies to either SpCBFbeta or SLBP (a positive control for the presence of intact protein in the egg and early embryo extracts).
###end p 87
###begin p 88
###xml 0 31 0 28 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Spatial expression of SpCBF&#946;</bold>
Spatial expression of SpCBFbeta. Whole mount in situ hybridization of (A-G) Two day old gastrula stage embryos showing global expression, with enrichment in endoderm (e) and parts of the oral ectoderm (oe), and (H-K) four day old pluteus showing expression localized to midgut (m) and hindgut (h) endoderm, and some expression in the ciliated band of the anal arm buds (K, arrows).
###end p 88
###begin p 89
###xml 0 56 0 53 <bold xmlns:xlink="http://www.w3.org/1999/xlink">Comparison of SpCBF&#946; and SpRunt-1 morphant phenotypes</bold>
Comparison of SpCBFbeta and SpRunt-1 morphant phenotypes. DIC images of (A) 24 h and (B) 72 h control MASO injected embryos; arrow in (B) points to skeletal rod (spicule); (C) 24 h and (D) 72 h SpRunt-1 MASO injected embryos; and (E) 24 h and (F) 72 h SpCBFbeta MASO injected embryos; black arrow in (F) points to tripartite gut, and white arrowhead points to a "ventrolateral" cluster of skeletogenic mesenchyme cells. Scale bars = 20 mum; embryos in (A), (C), (D) and (E) are to the same scale. (G) Immunoblot of total blastula-stage embryo extract showing that the SpCBFbeta MASO is effective in depleting endogenous SpCBFbeta (arrow).
###end p 89
###begin p 90
###xml 0 72 0 69 <bold xmlns:xlink="http://www.w3.org/1999/xlink">SpCBF&#946; does not contribute to the anti-apoptotic function of SpRunt-1</bold>
SpCBFbeta does not contribute to the anti-apoptotic function of SpRunt-1. (A) Gastrula stage SpRunt-1 morphant fluorescently imaged with TUNEL (green, indicating apoptosis) and DAPI (blue, indicating DNA). (B) Gastrula stage SpCBFbeta morphant fluorescently imaged with TUNEL and DAPI as in (A). (C) EMSA of recombinant wild-type and mutant (G115R) Runt domain (alpha) from SpRunt-1, in the presence or absence of recombinant SpCBFbeta. Note that while the G115R mutant Runt domain binds DNA, it does not heterodimerize with SpCBFbeta. (D) Gastrula stage SpRunt-1 morphant that has been co-injected with full-length mRNA encoding SpRunt-1-G115R, fluorescently imaged with TUNEL and DAPI as in (A). Note that while cell survival is rescued, as indicated by a lack of TUNEL signal, other aspects of development such as skeletogenesis are not.
###end p 90
###begin p 91
###xml 57 63 54 60 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SpPKC1</italic>
###xml 0 63 0 60 <bold xmlns:xlink="http://www.w3.org/1999/xlink">SpCBF&#946; is not involved in Runx-mediated regulation of <italic>SpPKC1</italic></bold>
###xml 99 105 96 102 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SpPKC1</italic>
###xml 107 113 104 110 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CyIIIa</italic>
###xml 115 125 112 122 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SpCyclinD </italic>
###xml 129 135 126 132 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SpDri </italic>
###xml 591 597 585 591 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CyIIIa</italic>
###xml 599 609 593 603 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SpCyclinD </italic>
###xml 613 619 607 613 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SpDri </italic>
###xml 814 820 802 808 <italic xmlns:xlink="http://www.w3.org/1999/xlink">CyIIIa</italic>
###xml 822 828 810 816 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SpPKC1</italic>
###xml 830 840 818 828 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SpCyclinD </italic>
###xml 844 851 832 839 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SpCdk4 </italic>
###xml 1121 1127 1106 1112 <italic xmlns:xlink="http://www.w3.org/1999/xlink">SpCdk4</italic>
SpCBFbeta is not involved in Runx-mediated regulation of SpPKC1. (A) Relative expression levels of SpPKC1, CyIIIa, SpCyclinD and SpDri as determined by RT-PCR analysis of RNA isolated from gastrula stage SpRunt-1-knockdown and SpCBFbeta-knockdown embryos. Each bar represents the average +/- standard deviation in the level of expression with respect to controls from two or more microinjection experiments. The dashed line indicates a 3-fold reduction of expression, which is taken here to be the minimum level of reduction considered to be significant. Note that whereas the expression of CyIIIa, SpCyclinD and SpDri are similarly affected by depletion of either SpRunt-1 or SpCBFbeta, expression of SpPKC1 is much more strongly affected by SpRunt-1 depletion than by SpCBFbeta depletion (asterisk). (B) ChIP of CyIIIa, SpPKC1, SpCyclinD and SpCdk4 using anti-SpRunt-1 and anti-SpCBFbeta antibodies and chromatin prepared from late gastrula stage (48 h) embryos. A product of the expected size was obtained from the input DNA with each primer set, confirming the efficacy of the primers and PCR conditions (not shown). SpCdk4, which was not recovered by ChIP with either antibody, was chosen as a specificity control because its expression levels are not affected by knockdown of either SpRunt-1 or SpCBFbeta.
###end p 91

